Evidence map›Paper›PMID 38958690›Full record

ReviewClinical and experimental medicine2024

Exploring regulatory mechanisms on miRNAs and their implications in inflammation-related diseases.

Emre Nalbant, Yeliz Z Akkaya-Ulum

Abstract readReview
In one paragraph

Review in Clinical and experimental medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Epigenetic regulation of EZH2 by ncRNAs: mechanisms and oncogenic implications.Naunyn-Schmiedeberg's archives of pharmacology · 2026
    Review
  9. Article
  10. The Epigenetic Landscape of Hemophilia.Current molecular medicine · 2026
    Review
  11. Integration of Omics Data to Identify Cancer-Related MicroRNA.Methods in molecular biology (Clifton, N.J.) · 2026
    Article
  12. Article
  13. Review
  14. Article
  15. Protective Role of Rosmarinic Acid-EnrichedBiochemistry research international · 2026
    Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. miR-184 in hepatocellular carcinoma: a promising therapeutic target.Journal of physiology and biochemistry · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Emre NalbantDepartment of Medical Biology, Faculty of Medicine, Hacettepe University, 06100, Sihhiye, Ankara, Türkiye.ORCID http://orcid.org/0009-0003-4184-7013
Yeliz Z Akkaya-UlumDepartment of Medical Biology, Faculty of Medicine, Hacettepe University, 06100, Sihhiye, Ankara, Türkiye. yelizakkaya@hacettepe.edu.tr.ORCID http://orcid.org/0000-0003-1888-2542

Funding

Hacettepe University, Scientific Research Projects Coordination Unit TKB-2023-20399Türkiye Bilimsel ve Teknolojik Araştırma Kurumu 222S604
6 · The paper itself

Abstract

This comprehensive exploration delves into the pivotal role of microRNAs (miRNAs) within the intricate tapestry of cellular regulation. As potent orchestrators of gene expression, miRNAs exhibit diverse functions in cellular processes, extending their influence from the nucleus to the cytoplasm. The complex journey of miRNA biogenesis, involving transcription, processing, and integration into the RNA-induced silencing complex, showcases their versatility. In the cytoplasm, mature miRNAs finely tune cellular functions by modulating target mRNA expression, while their reach extends into the nucleus, influencing transcriptional regulation and epigenetic modifications. Dysregulation of miRNAs becomes apparent in various pathologies, such as cancer, autoimmune diseases, and inflammatory conditions. The adaptability of miRNAs to environmental signals, interactions with transcription factors, and involvement in intricate regulatory networks underscore their significance. DNA methylation and histone modifications adds depth to understanding the dynamic regulation of miRNAs. Mechanisms like competition with RNA-binding proteins, sponging, and the control of miRNA levels through degradation and editing contribute to this complex regulation process. In this review, we mainly focus on how dysregulation of miRNA expression can be related with skin-related autoimmune and autoinflammatory diseases, arthritis, cardiovascular diseases, inflammatory bowel disease, autoimmune and autoinflammatory diseases, and neurodegenerative disorders. We also emphasize the multifaceted roles of miRNAs, urging continued research to unravel their complexities. The mechanisms governing miRNA functions promise advancements in therapeutic interventions and enhanced insights into cellular dynamics in health and disease.

Indexed as

Gene Expression RegulationInflammationMicroRNAsAutoimmune DiseasesEpigenesis, GeneticHumansNeurodegenerative DiseasesMicroRNAsCellular regulationEpigenetic modificationsInflammatory conditionsmicroRNAsTherapeutic interventions

Identifiers

PMID38958690
PMCPMC11222192

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.